ASND
Ascendis Pharma AS
227.80$
-0.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +124.6% | +44.2% | +11.0% | +51.2% | +112.2% | +44.8% | +10.7% | +0.4% | -24.2% | +42.9% | +10.4% | |
| – | +136.4% | +46.4% | +11.2% | +43.1% | +108.7% | +21.1% | +8.9% | +14.6% | -23.9% | +51.0% | +4.5% | |
| – | +138.5% | +50.7% | +8.3% | +42.2% | +115.3% | -2.3% | -23.7% | -0.3% | -11.8% | +42.7% | +10.1% | |
| – | +138.5% | +50.7% | +8.3% | +42.2% | +115.3% | +20.2% | -5.1% | +7.8% | -45.7% | +40.1% | +10.1% | |
| – | -17.6% | -73.0% | -34.5% | -96.8% | +13,300.0% | -51.9% | +468.5% | +441.4% | +201.2% | +363.5% | -5.2% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | -400.0% | – | +7,540,499,900.0% | +73.3% | +59.9% | +41.5% | +2.0% | |
| – | -14.2% | -0.2% | +8.8% | +69.1% | +942.1% | +139.9% | +16.6% | +2.4% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | 0.0% | |
| – | +0.0% | +8,639,776.8% | -100.0% | +31.6% | -4.5% | -49.4% | -20.0% | -25.0% | -30.7% | -42.3% | -59.7% | |
| – | -11.0% | +17.6% | +76.6% | +63.7% | +104.6% | +77.2% | +42.7% | +310.6% | +17.5% | +32.3% | +14.0% | |
| – | -11.0% | +17.6% | +76.6% | +63.7% | +23.3% | +10.0% | +90.1% | +614.2% | +2.8% | +23.3% | +17.7% | |
| – | – | – | – | – | – | +16.3% | +104.0% | +2,950.5% | +2.0% | +12.9% | -1.1% | |
| – | +68.9% | +56.2% | +33.3% | +13.2% | +40.7% | -21.1% | +171.3% | +70.0% | -6.4% | +1.9% | -6.0% | |
| – | – | – | – | – | – | – | – | +393.0% | +10.6% | -31.7% | +5.5% | |
| – | +162.7% | +46.8% | +6.0% | +49.6% | +113.2% | +40.5% | +5.4% | -70.2% | -155.3% | – | – | |
| – | +181.3% | -225.2% | – | – | – | – | – | – | – | – | – | |
| – | +40.3% | +11.8% | +26.6% | +22.2% | +13.2% | +8.8% | +8.2% | +2.4% | +0.4% | +2.9% | +4.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.